Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis

Magnetic Resonance Imaging

Volumn 33, Issue 1, 2015, Pages 26-30

  Ichikawa, Shintaro ^a   Motosugi, Utaroh ^a,b   Morisaka, Hiroyuki ^a   Sano, Katsuhiro ^a   Ichikawa, Tomoaki ^a   Tatsumi, Akihisa ^a   Enomoto, Nobuyuki ^a   Matsuda, Masanori ^a   Fujii, Hideki ^a   Onishi, Hiroshi ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Hepatic fibrosis; Liver stiffness; Magnetic resonance elastography; Transient elastography

Indexed keywords

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELASTOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INSTITUTIONAL REVIEW; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER RESECTION; MAGNETIC RESONANCE ELASTOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; TRANSIENT ELASTOGRAPHY; AGED; BIOPSY; COMPARATIVE STUDY; FIBROSIS; LIVER; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SURGERY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; ELASTICITY IMAGING TECHNIQUES; FEMALE; FIBROSIS; HUMANS; LIVER; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84926420209     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2014.10.003     Document Type: Article

References (37)

1. Nakagawa H., Maeda S., Yoshida H., Tateishi R., Masuzaki R., Ohki T., et al. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer 2009, 125:2264-2269.
2. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993, 328:1797-1801.
3. Standish R.A., Cholongitas E., Dhillon A., Burroughs A.K., Dhillon A.P. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006, 55:569-578.
4. Bravo A.A., Sheth S.G., Chopra S. Liver biopsy. N Engl J Med 2001, 344:495-500.
5. Regev A., Berho M., Jeffers L.J., Milikowski C., Molina E.G., Pyrsopoulos N.T., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002, 97:2614-2618.
6. Friedrich-Rust M., Zeuzem S. Transient elastography (FibroScan) for the non-invasive assessment of liver fibrosis: current status and perspectives. Z Gastroenterol 2007, 45:387-394. [in German].
7. Fraquelli M., Rigamonti C. Diagnosis of cirrhosis by transient elastography: what is hidden behind misleading results. Hepatology 2007, 46:282. [author reply 283].
8. Friedrich-Rust M., Wunder K., Kriener S., Sotoudeh F., Richter S., Bojunga J., et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 2009, 252:595-604.
9. Motosugi U., Ichikawa T., Sano K., Sou H., Muhi A., Koshiishi T., et al. Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol 2010, 28:623-627.
10. Hines C.D., Bley T.A., Lindstrom M.J., Reeder S.B. Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging 2010, 31:725-731.
11. Shire N.J., Yin M., Chen J., Railkar R.A., Fox-Bosetti S., Johnson S.M., et al. Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C. J Magn Reson Imaging 2011, 34:947-955.
12. Ichikawa S., Motosugi U., Ichikawa T., Sano K., Morisaka H., Enomoto N., et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci 2012, 11:291-297.
13. Yin M., Talwalkar J.A., Glaser K.J., Manduca A., Grimm R.C., Rossman P.J., et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007, 5:1207-13.e2.
14. Bohte A.E., de Niet A., Jansen L., Bipat S., Nederveen A.J., Verheij J., et al. Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur Radiol 2014, 24:638-648.
15. Huwart L., Sempoux C., Vicaut E., Salameh N., Annet L., Danse E., et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008, 135:32-40.
16. Rouvière O., Yin M., Dresner M.A., Rossman P.J., Burgart L.J., Fidler J.L., et al. MR elastography of the liver: preliminary results. Radiology 2006, 240:440-448.
17. Mannelli L., Godfrey E., Graves M.J., Patterson A.J., Beddy P., Bowden D., et al. Magnetic resonance elastography: feasibility of liver stiffness measurements in healthy volunteers at 3T. Clin Radiol 2012, 67:258-262.
18. Manduca A., Oliphant T.E., Dresner M.A., Mahowald J.L., Kruse S.A., Amromin E., et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 2001, 5:237-254.
19. Talwalkar J.A., Yin M., Venkatesh S., Rossman P.J., Grimm R.C., Manduca A., et al. Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol 2009, 193:122-127.
20. Mitsufuji T., Shinagawa Y., Fujimitsu R., Urakawa H., Inoue K., Takano K., et al. Measurement consistency of MR elastography at 3.0T: comparison among three different region-of-interest placement methods. Jpn. J Radiol 2013, 31:336-341.
21. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
22. Sandrin L., Fourquet B., Hasquenoph J.M., Yon S., Fournier C., Mal F., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003, 29:1705-1713.
23. Foucher J., Castéra L., Bernard P.H., Adhoute X., Laharie D., Bertet J., et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006, 18:411-412.
24. Kim Y.K., Lee M.W., Lee W.J., Kim S.H., Rhim H., Lim J.H., et al. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤1.5cm in diameter). Invest Radiol 2012, 47:159-166.
25. Motosugi U., Ichikawa T., Araki T. Rules, roles, and room for discussion in gadoxetic acid-enhanced magnetic resonance liver imaging: current knowledge and future challenges. Magn Reson Med Sci 2013, 12:161-175.
26. Kim Y.K., Lee W.J., Park M.J., Kim S.H., Rhim H., Choi D. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Radiology 2012, 265:104-114.
27. Taouli B., Ehman R.L., Reeder S.B. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol 2009, 193:14-27.
28. Watanabe H., Kanematsu M., Goshima S., Kondo H., Onozuka M., Moriyama N., et al. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging-preliminary observations. Radiology 2011, 259:142-150.
29. Luciani A., Vignaud A., Cavet M., Nhieu J.T., Mallat A., Ruel L., et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008, 249:891-899.
30. Patel J., Sigmund E.E., Rusinek H., Oei M., Babb J.S., Taouli B. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010, 31:589-600.
31. Motosugi U., Ichikawa T., Oguri M., Sano K., Sou H., Muhi A., et al. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index. Magn Reson Imaging 2011, 29:1047-1052.
32. Wang Y., Ganger D.R., Levitsky J., Sternick L.A., McCarthy R.J., Chen Z.E., et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 2011, 196:553-561.
33. Wang Q.B., Zhu H., Liu H.L., Zhang B. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 2012, 56:239-247.
34. Chen J., Talwalkar J.A., Yin M., Glaser K.J., Sanderson S.O., Ehman R.L. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011, 259:749-756.
35. Motosugi U., Ichikawa T., Niitsuma Y., Araki T. Acoustic radiation force impulse elastography of the liver: can fat deposition in the liver affect the measurement of liver stiffness?. Jpn J Radiol 2011, 29:639-643.
36. Guo Y., Parthasarathy S., Goyal P., McCarthy R.J., Larson A.C., Miller F.H. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging 2014, [Epub ahead of print].
37. Yoon J.H., Lee J.M., Woo H.S., Yu M.H., Joo I., Lee E.S., et al. Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals. Korean J Radiol 2013, 14:202-212.